Elaine Morrato
Elaine H. Morrato, DrPH MPH FISPE CPH, is professor and founding dean of the Parkinson School of Health Sciences and Public Health at Loyola University Chicago. Trained in epidemiology and board-certified in public health, her work focuses on accelerating the translation of evidence into practice with a particular focus on drug safety. Her global pharmaceutical industry experience at Procter and Gamble developing and commercializing new drugs and indications informs her implementation science research and practice.
Morrato remains active in the NIH Clinical & Translational Sciences Award (CSTA) program where she directs Loyola’s collaboration with the University of Chicago-Rush University Institute for Translational Medicine. She contributed to the national expansion of the NIH Innovation-Corps (I-Corps)™ training program for ensuring problem-solution fit and the scale-up and sustainability of academic innovation. She regularly advises the U.S. Food and Drug Administration on issues of pharmaceutical risk communication and management and completed a visiting professorship with the Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research.
Morrato has been awarded the University of Colorado’s President’s Excellence in Teaching award (2012) and the AHRQ career development award on “Accelerating the Diffusion of Comparative Effectiveness into Clinical Practice.”
Morrato earned her BS (Honors) summa cum laude from Purdue University, Indiana, her DrPH and MPH from Johns Hopkins University’s Bloomberg School of Public Health, and received her Board Certification in Public Health from the National Board of Public Health Examiners. She is an inducted Fellow in the International Society of Pharmacoepidemiology and in the Institute of Medicine of Chicago. She also received an Executive Certificate from the Kellogg School of Management at Northwestern University.
Elaine H. Morrato, DrPH MPH FISPE CPH, is professor and founding dean of the Parkinson School of Health Sciences and Public Health at Loyola University Chicago. Trained in epidemiology and board-certified in public health, her work focuses on accelerating the translation of evidence into practice with a particular focus on drug safety. Her global pharmaceutical industry experience at Procter and Gamble developing and commercializing new drugs and indications informs her implementation science research and practice.
Morrato remains active in the NIH Clinical & Translational Sciences Award (CSTA) program where she directs Loyola’s collaboration with the University of Chicago-Rush University Institute for Translational Medicine. She contributed to the national expansion of the NIH Innovation-Corps (I-Corps)™ training program for ensuring problem-solution fit and the scale-up and sustainability of academic innovation. She regularly advises the U.S. Food and Drug Administration on issues of pharmaceutical risk communication and management and completed a visiting professorship with the Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research.
Morrato has been awarded the University of Colorado’s President’s Excellence in Teaching award (2012) and the AHRQ career development award on “Accelerating the Diffusion of Comparative Effectiveness into Clinical Practice.”
Morrato earned her BS (Honors) summa cum laude from Purdue University, Indiana, her DrPH and MPH from Johns Hopkins University’s Bloomberg School of Public Health, and received her Board Certification in Public Health from the National Board of Public Health Examiners. She is an inducted Fellow in the International Society of Pharmacoepidemiology and in the Institute of Medicine of Chicago. She also received an Executive Certificate from the Kellogg School of Management at Northwestern University.